EUVIMEDEUVIMED entdecken
Crossref

Genetic Susceptibility and Inflammatory Mechanisms in Bortezomib‐Induced Peripheral Neuropathy: Insights From Whole Exome Sequencing and Transcriptomic Analysis

JiaLin Zhou, HanHeng Mai, YunQing Liu, Na Wang, Xiao Lyu, QingDan Meng, LiLi Feng iD

Journal of Applied Toxicology · 2026-12 · 46 (12) · 4623-4635

DOI: 10.1002/jat.70200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 29.04.2026. Verfasst von JiaLin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First…. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Bortezomib, Genetic Predisposition to Disease, Antineoplastic Agents. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Key Research and Development Projects of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inter‐individual variability in patient susceptibility to bortezomib (BTZ)‐induced peripheral neuropathy (BIPN) suggests a potential role of genetic predisposition. However, the comprehensive mutational landscape and its functional relevance remain poorly defined. We aimed to characterize the genetic architecture and inflammatory mechanisms underlying BIPN in multiple myeloma (MM) patients. Whole exome sequencing (WES) was performed on peripheral blood mononuclear cells (PBMCs) from 20 newly diagnosed MM patients treated with BTZ, including eight patients who developed grade ≥ 2 BIPN and 12 controls without neuropathy. To functionally interpret genetic alterations, WES data were integrated with transcriptomic datasets from chemotherapy‐induced peripheral neuropathy models obtained from GEO databases. Enrichment analyses and molecular docking were conducted to identify key driver genes and potential BTZ‐protein interactions. WES identified 90,465 BIPN‐associated single nucleotide polymorphisms, with a distinct co‐mutation signature involving 33 zinc‐finger (ZNF) family genes. Integrative multi‐omics analysis yielded 100 candidate genes enriched in inflammatory response, neuronal development, synaptic organization, and MAPK/NF‐κB signaling pathways. Three key genes— CACNA1H , CIC , and ABLIM2 —were identified as potential driver genes and demonstrated direct binding affinity with BTZ in docking analyses. Notably, enrichment analyses also suggested shared molecular mechanisms between neurotoxicity and cardiotoxicity. Our findings revealed that inflammation‐driven neuronal dysfunction mediated by genetic susceptibility represented a central mechanism of BIPN. Integrative genomic profiling might provide a framework for personalized risk assessment and precision management of BTZ‐related neurotoxicity and associated organ toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesBortezomibGenetic Predisposition to DiseaseAntineoplastic AgentsTranscriptomeInflammationHumansExome SequencingMaleGene Expression ProfilingFemalePolymorphism, Single NucleotideMultiple MyelomaMiddle AgedAgedMolecular Docking Simulation

Stichwörter der Autor:innen

bortezomib‐induced peripheral neuropathygenetic susceptibilitygenomic profilinginflammatory responsemultiple myelomapersonalized cancer therapyrisk assessment

Substanzen

BortezomibAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiation Oncology and Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, S…
  • First Clinical Institute of Shantou University Medical College, Shantou, Guangdong, China.
  • Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Shandong Second Medical University, Weifang, Shandong, China.
  • Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Department of Hematology, Anqiu People's Hospital, Shandong Second Medical University, Weifang, Shandong, China.

ORCID-Profile: LiLi Feng

Förderung

  • Natural Science Foundation of Shandong Province
  • Key Research and Development Projects of Shandong Province

Zitieren

APA

Zhou, J., Mai, H., Liu, Y., Wang, N., Lyu, X., Meng, Q., & Feng, L. (2026). Genetic Susceptibility and Inflammatory Mechanisms in Bortezomib‐Induced Peripheral Neuropathy: Insights From Whole Exome Sequencing and Transcriptomic Analysis. Journal of Applied Toxicology, 46(12), 4623-4635. https://doi.org/10.1002/jat.70200

Vancouver

Zhou J, Mai H, Liu Y, Wang N, Lyu X, Meng Q, et al. Genetic Susceptibility and Inflammatory Mechanisms in Bortezomib‐Induced Peripheral Neuropathy: Insights From Whole Exome Sequencing and Transcriptomic Analysis. Journal of Applied Toxicology. 2026;46(12):4623-4635. doi:10.1002/jat.70200

BibTeX
@article{Zhou2026,
  author = {Zhou, JiaLin and Mai, HanHeng and Liu, YunQing and Wang, Na and Lyu, Xiao and Meng, QingDan and Feng, LiLi},
  title = {Genetic Susceptibility and Inflammatory Mechanisms in Bortezomib‐Induced Peripheral Neuropathy: Insights From Whole Exome Sequencing and Transcriptomic Analysis},
  journal = {Journal of Applied Toxicology},
  year = {2026},
  volume = {46},
  number = {12},
  pages = {4623--4635},
  doi = {10.1002/jat.70200}
}
Kostenlos starten →